Pharmacological approaches of ADHD

Eur Psychiatry · 2021 · PMC9471268

Europe PMC

hedged sentence

0.0300

closest p · 0.6× alpha

0.0300

boldest claim

The sentences

nominally significantp=0.03actually significant

For secondary outcomes Sativex was associated with a nominally significant improvement in hyperactivity/impulsivity (p=0.03) and a cognitive measure of inhibition (p=0.05), and a trend towards improvement for inattention (p=0.10) and EL (p=0.11).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.